You searched for "New Zealand"
Licence to save: a UK survey of anti-VEGF use for the eye
This comment article highlights the controversy that exists in the choice for anti-VEGF drugs used for treatment of macular oedema and wet age-related macular degeneration (AMD). Two existing licensed drugs for macular oedema are ranibizumab (Lucentis) and aflibercept (Eylea). A...UK rejoins Horizon Europe research funding programme
The UK government has announced that it will rejoin the €95bn Horizon Europe research framework.WHO SPECS 2030: a global initiative to strengthen refractive error services
Globally, it is estimated that only around one-third of people with vision impairment due to refractive error have received access to a quality pair of spectacles [1]. In recognition that uncorrected refractive error is the leading cause of vision impairment...Update on emerging therapies for age-related macular degeneration
The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...
